Somnomed Ltd - Asset Resilience Ratio
Somnomed Ltd (SOM) has an Asset Resilience Ratio of 24.67% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read SOM total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how Somnomed Ltd's Asset Resilience Ratio has changed over time. See shareholders equity of Somnomed Ltd for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Somnomed Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Somnomed Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$18.50 Million | 24.67% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$18.50 Million | 24.67% |
Asset Resilience Insights
- Good Liquidity Position: Somnomed Ltd maintains a healthy 24.67% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Somnomed Ltd Industry Peers by Asset Resilience Ratio
Compare Somnomed Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 36.63% |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298 |
Medical Devices | 2.82% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 9.52% |
|
Guangdong Transtek Medical Electronics Co Ltd
SHE:300562 |
Medical Devices | 14.72% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.47% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 0.50% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.39% |
Annual Asset Resilience Ratio for Somnomed Ltd (2016–2024)
The table below shows the annual Asset Resilience Ratio data for Somnomed Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-06-30 | 23.18% | AU$16.18 Million ≈ $11.45 Million |
AU$69.80 Million ≈ $49.39 Million |
+4.04pp |
| 2023-06-30 | 19.13% | AU$11.96 Million ≈ $8.46 Million |
AU$62.49 Million ≈ $44.22 Million |
-7.80pp |
| 2022-06-30 | 26.93% | AU$15.64 Million ≈ $11.07 Million |
AU$58.09 Million ≈ $41.10 Million |
-10.65pp |
| 2021-06-30 | 37.58% | AU$21.11 Million ≈ $14.94 Million |
AU$56.17 Million ≈ $39.74 Million |
-11.33pp |
| 2020-06-30 | 48.91% | AU$30.17 Million ≈ $21.35 Million |
AU$61.69 Million ≈ $43.65 Million |
+26.76pp |
| 2019-06-30 | 22.15% | AU$7.70 Million ≈ $5.45 Million |
AU$34.75 Million ≈ $24.59 Million |
-7.14pp |
| 2018-06-30 | 29.29% | AU$13.38 Million ≈ $9.47 Million |
AU$45.70 Million ≈ $32.33 Million |
-5.19pp |
| 2017-06-30 | 34.48% | AU$14.21 Million ≈ $10.05 Million |
AU$41.21 Million ≈ $29.16 Million |
-- |
| 2016-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$40.43 Million ≈ $28.60 Million |
-- |
About Somnomed Ltd
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product desig… Read more